12:00 AM
 | 
Dec 14, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

TNF-alpha kinoid: Phase IIa started

Neovacs began a double-blind, placebo-controlled, European Phase IIa trial in up to 48 patients who ceased responding to an anti-TNF mAb...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >